INS and fatty liver disease: Additionally, hepatokines may modulate the actions of other exercise-inducible factors, thus inhibiting fat accumulation; this favors SkM adaptation to exercise and an anti-inflammatory pro-browning environment that promotes loss of fat mass, attenuation of hepatic steatosis, and decreased insulin resistance.